<informationTable xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable">
  <infoTable>
    <nameOfIssuer>Alumis Inc.</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>022307102</cusip>
    <value>15404782</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1959896</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1959896</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Arcellx, Inc.</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>03940C100</cusip>
    <value>179963055</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2346630</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2346630</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ARS Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>82835W108</cusip>
    <value>42336127</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4012903</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4012903</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CRISPR Therapeutics AG</nameOfIssuer>
    <titleOfClass>Common Shares</titleOfClass>
    <cusip>H17182108</cusip>
    <value>41286711</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1048951</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1048951</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Design Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>25056L103</cusip>
    <value>40268357</value>
    <shrsOrPrnAmt>
      <sshPrnamt>6526476</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>6526476</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>enGene Holdings Inc.</nameOfIssuer>
    <titleOfClass>Common Shares</titleOfClass>
    <cusip>29286M105</cusip>
    <value>4972537</value>
    <shrsOrPrnAmt>
      <sshPrnamt>747750</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>747750</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>KALA Bio, Inc.</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>483119202</cusip>
    <value>4156644</value>
    <shrsOrPrnAmt>
      <sshPrnamt>598940</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>598940</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Mineralys Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>603170101</cusip>
    <value>24827079</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2016822</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2016822</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Nkarta, Inc.</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>65487U108</cusip>
    <value>8299999</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3333333</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3333333</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Oruka Therapeutics, Inc</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>687604108</cusip>
    <value>8344099</value>
    <shrsOrPrnAmt>
      <sshPrnamt>430330</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>430330</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Zenas BioPharma, Inc</nameOfIssuer>
    <titleOfClass>Common Stock</titleOfClass>
    <cusip>98937L105</cusip>
    <value>40225504</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4911539</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4911539</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
</informationTable>
